26 Sep 2018 | 7:20 AM
 

Ajanta Pharma Ltd. Share Price Live (BSE)
0

BSE Code: 532331 | NSE Symbol: AJANTPHARM
1,112.70
23.65
(2.18 %)
25 Sep 2018 | 03:47 PM
Change company
  • Open (Rs)
    1,087.10
  • Prev. close (Rs.)
    1,089.05
  • High (Rs.)
    1,116.00
  • Low (Rs.)
    1,077.00
  • 52W H (Rs.)
    1,592.00
  • 52W L (Rs.)
    897.60
  • Volume
    23472
  • MCap (Rs in Cr.)
    9,793.55
1114.8
21.80
(1.99 %)
  • Open (Rs)
    1,085.00
  • High (Rs)
    1,119.95
  • Low (Rs)
    1,073.90
  • Prev. close(Rs)
    1,093.00
  • Contracts Tra.
    6,07,000
  • Turnover (Cr.)
    67
  • Open Interest
    5,71,500
  • Open Int. chg
    -31,000.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
53.25
Operating Margin (%)
30.97
Gross Profit Margin (%)
28.16
Net Profit Margin (%)
22.04
Total Debt/Equity
0.00
Dividend payout Ratio (Net Profit)
0.00
Earning Retention Ratio
100.00

News

31 Jul 2018 - 16:44:00-Ajanta Pharma today reported 11.60 per cent rise in consolidated net profit at Rs 105...
27 Jul 2018 - 14:47:00-Drug firm Ajanta Pharma today said the US health regulator has not made any observations after compl...
03 May 2018 - 14:50:00-The company reported standalone net profit of Rs 78...
25 Jan 2018 - 15:54:00-The company reported standalone net profit of Rs 1...

Announcements

14-Sep-2018
Ajanta Pharma Lt - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
14-Sep-2018
Ajanta Pharma Lt - Allotment of ESOP/ESPS
10-Sep-2018
Ajanta Pharma Lt - Announcement under Regulation 30 (LODR)-Scheme of Arrangement
10-Sep-2018
Ajanta Pharma Lt - Scheme of Arrangement
30-Aug-2018
Ajanta Pharma Lt - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Religare Research

25 Sep 2018 | 10:27 AM
Daily Techno Funda
25 Sep 2018 | 10:12 AM
The rupee ended at 72.63 to a dollar, against 72.20 at close on Sep. 21. It fell to 72.73 intraday, ...
25 Sep 2018 | 09:51 AM
Highlights: Agri markets traded with high volatility as rains in some parts of North-West India kep...
25 Sep 2018 | 07:00 AM
Traders should maintain extra caution at present and avoid naked leveraged positions. We suggest usi...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
8,84,202 132.61 25.01 0.86
8,84,202 132.61 23.00 0.86
8,84,202 132.61 24.08 0.87
8,84,202 132.61 26.10 0.87
2,50,161 37.52 24.75 0.25

Shareholding Pattern

       
Promotors70.48%
Mutual Funds/UTI7.42%
FI/Banks0.55%
Insurance0.55%
FII10.52%
Government0.34%
Others1.47%

Peer Group

Company Intraday Graph
 Merck Ltd.
2,727.60(-4.04)
3302
 AstraZeneca Pharma India Ltd.
1,663.10(-0.58)
3274
 Dr. Lal Pathlabs Ltd.
960.50(1.07)
17140
 Ipca Laboratories Ltd.
701.20(-2.19)
3488

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Ajanta Pharma Ltd.-118.8071.85-288.05
NIFTY(S&P CNX)-624.50305.00936.80
BSE SENSEX-2,042.051,181.713,585.65
BSE 500-1,044.92105.29635.78

Corporate Details

Key Personal
Madhusudan B Agrawal
Vice Chairman
Mannalal B Agrawal
Chairman
Purushottam B Agrawal
Vice Chairman
Key Address
Registered Office
Ajanta House Charkop Kandivli (West),Mumbai,Maharashtra

Tel:022-66061000, Fax:022-66061200 66061300

investorgrievance@ajantapharma.com
http://www.ajantapharma.com
Registrar Office
Link Intime India Pvt. Ltd.
Add. :C 101 247 Park ? L.B.S. Marg Vikhroli (West)